Clinical Trial Update: 3T Therapy in the Treatment of MDA5-positive Dermatomyositis [Phase 4]

View source ↗

Summary

The document reports an ongoing Phase 4 clinical trial evaluating 3T Therapy for MDA5-positive Dermatomyositis, with enrollment by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis

Drugs mentioned

• 3T Therapy

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Dermatomyositis | Phase 4 | Status: ENROLLING_BY_INVITATION